Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc ENHancement of Immunological Response (pilot add-on study)
2010-019518-25Phase 3Active
- Sponsor
- Papa Giovanni XXIII Hospital
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by Papa Giovanni XXIII Hospital. Primary endpoint: Immunological recovery at 6 months. Started May 2010; status: active.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2010-019518-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019518-25.